Browse News
Filter News
Found 561,802 articles
-
Sanofi will be responsible for leading the clinical program and funding all studies needed to support the over-the-counter switch in the United States and will also be responsible for the regulatory submissions.
-
If you are feeling undervalued at work, it’s productive to think about how you’ve demonstrated your value internally. Here are four ways to demonstrate your worth in the workplace!
-
At 96 weeks, 60% of the heavily pretreated HIV patients dosed with ViiV's experimental treatment achieved virologic suppression.
-
In the trial, 396 patients with moderate-to-severe psychotic symptoms related to adult schizophrenia received either Nuplazid or placebo added to their current antipsychotic treatment. The patients receiving Nuplazid showed a consistent trend in symptom improvement but did not hit statistical sig...
-
A new technique, DNA microscopy, is allowing scientists to visualize DNA in a way not previously possible. And there isn’t even an actual microscope involved.
-
With the positive results from this trial, as well as an earlier Phase III trial, Myovant Sciences plans to seek regulatory approval later this year.
-
"Our ultimate goal is to provide a solution to an organ shortage that causes an average of 20 people per day in the US alone to die waiting for an organ transplant," quoted Rich Boling, the vice-president of corporate advancement at Techshot.
-
Today, Civica Rx announced a five-year deal with London, UK-based Hikma Pharmaceuticals to manufacture and supply Civica’s members with 14 sterile injectable drugs as a private label distributor.
-
Researchers with the Weizmann Institute of Science worked with mice with an ALS-like disease. They found that the course of the disease slowed after the mice received specific strains of gut microbes or substances that were secreted by the microbes. The results suggest that the microbiome may pla...
-
Luna Design and Innovation selected as a Channel Partner for Blue Origin
7/23/2019
Luna Design and Innovation Inc., a Toronto-based biotechnology company, announced that it has been selected as an Official Channel Partner for Blue Origin’s New Shepard reusable suborbital rocket system.
-
FDA warns company marketing unapproved cannabidiol products with unsubstantiated claims to treat cancer, Alzheimer's disease, opioid withdrawal, pain and pet anxiety
7/23/2019
Agency is expediting work to evaluate regulatory policies related to cannabis and cannabis-derived ingredients like CBD
-
Raleigh Neurology Associates Brings Specialty Clinical Data Set to the TriNetX Research Network
7/23/2019
Raleigh Neurology Associates, one of the largest private neurology practices in the U.S, has joined the TriNetX global health research network adding a significant new clinical data set to the world's largest research network.
-
Parexel Extends Asia/Pacific Capability with the Launch of Health Advances Asia Limited
7/23/2019
Strategic Healthcare Consulting subsidiary will support development of global expansion strategies for Asia/Pacific and multinational companies from new Hong Kong presence; biopharma and medtech veteran Gary Cheng to lead local team
-
Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a Stock for Stock Transaction Valuing Therapix at US$48 Million
7/23/2019
The transaction will create a combined company that focuses on Therapix's proprietary IP and related technology, and assets pertaining to all clinical stage pharmaceutical applications and Destiny's genomics-based breeding techniques and development capabilities.
-
ClinOne to Offer Free Patient Recruitment to Clinical Trial Sponsors In 2020
7/23/2019
The technology will allow patients to navigate clinical trial options near their home or place of work.
-
Kalderos Announces Strategic Hires
7/23/2019
The leader in drug discount management software adds a variety of talent to advance mission of adding transparency to the business of health care.
-
The Gray Foundation Announces $25 Million in New Team Science Funding for BRCA-Related Cancer Research
7/23/2019
Grants to 7 Research Teams Raises the Foundation’s Giving to BRCA Causes to over $100 Million
-
CEL-SCI’s Scientific Review on Inflammatory Disease Therapies Published in Peer Reviewed Journal “International Immunopharmacology”
7/23/2019
This review proposes a new approach to treating autoimmune and inflammatory diseases based on lessons from new generation influenza vaccines.
-
Cytena Founds Subsidiary in Taiwan
7/23/2019
Cytena Bioprocess Solutions is developing an innovative technology, which enables considerable reductions in time and increases in efficiency for cell line development.
-
The DynaNail® TTC Fusion System Demonstrates Favorable Outcomes in Challenging Patient Populations
7/23/2019
New clinical findings reported in multiple peer-reviewed studies